Table 1. Anti-cancer drugs benefitted by liposome .

Drug	Lipid Component	Interpretation	Special feature	Ref.
Raloxifene hydrochloride	DSPC: Cholesterol, diethylene triamine penta acetic acid	Raloxifene loaded liposomal formulation provided effective uterine targeting as compared to non-liposomal drug.	Gamma scintigraphy studies depicted selective uptake of radiolabeled RLH.	69
Raloxifene	Dipalmitoyl phosph-atidylcholine, dioctyl phosphatidyl choline and calcium chloride. Dimethyl-β-cyclodextrin and sodium taurocholate	Raloxifene dimethyl-β-CD cochleate formulations were found to be successful in reducing breast tumors. Further matrix metalloproteinase-2 (MMP-2) enzyme was also found to be inhibited.	MCF-7 cell lines were used to evaluate antitumor activity.	70
Adriamycin	EPC/Chol 55:45 Chloroform, isopropanol, Water.	Adriamycin loaded liposome on local administration effectively inhibiting the proliferating cells by inducing apoptosis thereby reducing lymph node metastasis.	Highest apoptotic index of 21.73%.	71
Doxorubicin	Phosphatidylcholine, and cholesterol	Doxorubicin-loaded liposomes offered enhanced permeability and retention effect.	Passive targeting at cancer cells.	72